Amy Scott-Thomas

Dr. Amy Scott-Thomas

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2010 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
ASAmy Scott-Thomas
Amy Scott-Thomas
MSMona Syhre
Mona Syhre
PPPhilip K Pattemore
Philip K Pattemore
MEMichael Epton
Michael Epton
RLRichard Laing
Richard Laing
SCStephen Thomas Chambers
Stephen Thomas Chambers
Pseudomonas aeruginosa infections are associated with progressive life threatening decline of lung function in cystic fibrosis sufferers. Growth of Ps. aeruginosa releases a "grape-like" odour that has been identified as the microbial volatile organic compound 2-aminoacetophenone (2-AA).

31 January 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
SCStephen Thomas Chambers
Stephen Thomas Chambers
SSSandy Slow
Sandy Slow
ASAmy Scott-Thomas
Amy Scott-Thomas
DMDavid Murdoch
David Murdoch
Although known as causes of community-acquired pneumonia and Pontiac fever, the global burden of infection caused by Legionella species other than Legionella pneumophila is under-recognised. Non-L. pneumophila legionellae have a worldwide distribution, although common testing strategies for legionellosis favour detection of L. pneumophila over other Legionella species, leading to an inherent diagnostic bias and under-detection of cases. When systematically tested for in Australia and New Zealand, L. longbeachae was shown to be a leading cause of community-acquired pneumonia. Exposure to potting soils and compost is a particular risk for infection from L. longbeachae, and L. longbeachae may be better adapted to soil and composting plant material than other Legionella species. It is possible that the high rate of L. longbeachae reported in Australia and New Zealand is related to the composition of commercial potting soils which, unlike European products, contain pine bark and sawdust. Genetic studies have demonstrated that the Legionella genomes are highly plastic, with areas of the chromosome showing high levels of recombination as well as horizontal gene transfer both within and between species via plasmids. This, combined with various secretion systems and extensive effector repertoires that enable the bacterium to hijack host cell functions and resources, is instrumental in shaping its pathogenesis, survival and growth. Prevention of legionellosis is hampered by surveillance systems that are compromised by ascertainment bias, which limits commitment to an effective public health response. Current prevention strategies in Australia and New Zealand are directed at individual gardeners who use potting soils and compost. This consists of advice to avoid aerosols generated by the use of potting soils and use masks and gloves, but there is little evidence that this is effective. There is a need to better understand the epidemiology of L. longbeachae and other Legionella species in order to develop effective treatment and preventative strategies globally.

Verified
Journal Article
Open access
PDF file
ASAqsa Shahid
Aqsa Shahid
SCStephen Thomas Chambers
Stephen Thomas Chambers
ASAmy Scott-Thomas
Amy Scott-Thomas
Madhav BhatiaMadhav Bhatia
Madhav Bhatia
Sepsis is a life-threatening complication caused by an uncontrolled immune response to infection that can lead to multi-organ dysfunction, including liver injury. Recent research has shown the critical role of gut microbiota in sepsis pathogenesis, with the gut–liver axis playing a crucial role in disease progression. Mechanisms such as the disruption of the gut barrier and liver injury pathways mediated by cytokines, chemokines, adhesion molecules, hydrogen sulfide (H2S). and substance P (SP) have been the focus of recent studies. Some potential biomarkers and gut microbiota-targeted therapies have shown promise as emerging tools for predicting and managing sepsis. This review describes the role of the gut–liver axis in sepsis and the potential of microbiota-targeted therapies and biomarker-driven interventions to improve sepsis outcomes.

Verified
Journal Article
Open access
PDF file
XLXihua Lian
Xihua Lian
ASAmy Scott-Thomas
Amy Scott-Thomas
JLJohn G Lewis
John G Lewis
Madhav BhatiaMadhav Bhatia
Madhav Bhatia
SMSean A. MacPherson
Sean A. MacPherson
SCStephen Thomas Chambers
Stephen Thomas Chambers
Invasive aspergillosis (IA) is a life-threatening fungal disease that causes high morbidity and mortality in immunosuppressed patients. Early and accurate diagnosis and treatment of IA remain challenging. Given the broad range of non-specific clinical symptoms and the shortcomings of current diagnostic techniques, most patients are either diagnosed as “possible” or “probable” cases but not “proven”. Moreover, because of the lack of sensitive and specific tests, many high-risk patients receive an empirical therapy or a prolonged treatment of high-priced antifungal agents, leading to unnecessary adverse effects and a high risk of drug resistance. More precise diagnostic techniques alongside a targeted antifungal treatment are fundamental requirements for reducing the morbidity and mortality of IA. Monoclonal antibodies (mAbs) with high specificity in targeting the corresponding antigen(s) may have the potential to improve diagnostic tests and form the basis for novel IA treatments. This review summarizes the up-to-date application of mAb-based approaches in assisting IA diagnosis and therapy.

18 July 2013 in Journal of Breath Research
Verified
Journal Article
Closed access
PDF file
ASAmy Scott-Thomas
Amy Scott-Thomas
MEMichael Epton
Michael Epton
SCStephen Thomas Chambers
Stephen Thomas Chambers
Mycobacterium tuberculosis releases four volatile compounds, methyl phenyl-acetate, methyl nicotinate, methyl p-anisate and o-phenylanisole, some of which we have previously been reported to be detected in the breath of tuberculosis patients (Syhre et al 2009 Tuberculosis 89 263–6). These volatiles have the potential to offer a non-invasive and sensitive breath test for the detection of tuberculosis infection. To determine the best sample collection and pre-concentration system a number of variables were examined. The four markers were most stable when breath was collected in a salinized glass sampling bulb compared to either Tedlar® TA, SupelTM Inert Foil or SupelTM Inert Gas bags. Concentration of breath onto thermal desorption cartridges indicated that Tenax® TA was the most universal sorbent for the collection of all four volatiles. Increasing the number of breath exhalations captured and analysed actively increased the detectable level of volatiles. The most important discovery was samples of methyl nicotinate, methyl p-anisate and o-phenylanisole remained stable on Tenax® TA cartridges for over two months at various altitudes.

1 May 2013 in Tuberculosis
Verified
Journal Article
Closed access
ASAmy Scott-Thomas
Amy Scott-Thomas
MSMona Syhre
Mona Syhre
MEMichael Epton
Michael Epton
DMDavid R. Murdoch
David R. Murdoch
SCStephen Thomas Chambers
Stephen Thomas Chambers